OBJECTIVE: Among Alzheimer disease (AD) patients enrolled in a clinical trial, the authors assessed the ability of a standardized capacity assessment procedure to identify persons who are capable of giving their own informed consent. DESIGN: Cross-sectional interview. SETTING:Thirteen sites participating in a randomized andplacebo controlled study of simvastatin for the treatment of mild to moderate AD. PARTICIPANTS: Persons with mild to moderate AD and their study partners enrolled in the simvastatin clinical trial. MEASUREMENTS: Interviews to assess decision-making capacity using the MacArthur Competency Assessment Tool for Clinical Research (MacCAT-CR). RESULTS: Judges blinded to the subject's clinical status had a high rate of agreement on patients capable of giving their own informed consent (kappa = 0.73). The understanding subscale had the best receiver operator characteristic and an analysis of positive and negative predictive values over a range of hypothetical prevalences of incapacity to consent demonstrated the value of a range of understanding cut-points. CONCLUSION: Among mild to moderate AD patients, enrolled in an actual clinical trial, these results suggest evidence based guidelines for using the MacCAT-CR understanding subscale to help guide judgments about whether a patient has the capacity to consent.
RCT Entities:
OBJECTIVE: Among Alzheimer disease (AD) patients enrolled in a clinical trial, the authors assessed the ability of a standardized capacity assessment procedure to identify persons who are capable of giving their own informed consent. DESIGN: Cross-sectional interview. SETTING: Thirteen sites participating in a randomized and placebo controlled study of simvastatin for the treatment of mild to moderate AD. PARTICIPANTS: Persons with mild to moderate AD and their study partners enrolled in the simvastatin clinical trial. MEASUREMENTS: Interviews to assess decision-making capacity using the MacArthur Competency Assessment Tool for Clinical Research (MacCAT-CR). RESULTS: Judges blinded to the subject's clinical status had a high rate of agreement on patients capable of giving their own informed consent (kappa = 0.73). The understanding subscale had the best receiver operator characteristic and an analysis of positive and negative predictive values over a range of hypothetical prevalences of incapacity to consent demonstrated the value of a range of understanding cut-points. CONCLUSION: Among mild to moderate ADpatients, enrolled in an actual clinical trial, these results suggest evidence based guidelines for using the MacCAT-CR understanding subscale to help guide judgments about whether a patient has the capacity to consent.
Authors: Barton W Palmer; Laura B Dunn; Paul S Appelbaum; Sunder Mudaliar; Leon Thal; Robert Henry; Shahrokh Golshan; Dilip V Jeste Journal: Arch Gen Psychiatry Date: 2005-07
Authors: Richard Schulz; Aaron B Mendelsohn; William E Haley; Diane Mahoney; Rebecca S Allen; Song Zhang; Larry Thompson; Steven H Belle Journal: N Engl J Med Date: 2003-11-13 Impact factor: 91.245
Authors: Scott Y H Kim; Paul S Appelbaum; Jeffrey Swan; T Scott Stroup; Joseph P McEvoy; Donald C Goff; Dilip V Jeste; J Steven Lamberti; Adrian Leibovici; Eric D Caine Journal: Br J Psychiatry Date: 2007-07 Impact factor: 9.319
Authors: Barton W Palmer; Alexandrea L Harmell; Luz L Pinto; Laura B Dunn; Scott Y H Kim; Shahrokh Golshan; Dilip V Jeste Journal: Clin Gerontol Date: 2016-06-07 Impact factor: 2.619
Authors: Stephen T Moelter; Daniel Weintraub; Lauren Mace; Mark Cary; Elizabeth Sullo; Sharon X Xie; Jason Karlawish Journal: Mov Disord Date: 2016-02-10 Impact factor: 10.338
Authors: Barton W Palmer; Alexandrea L Harmell; Laura B Dunn; Scott Y Kim; Luz L Pinto; Shahrokh Golshan; Dilip V Jeste Journal: Clin Gerontol Date: 2017-11-28 Impact factor: 2.619
Authors: Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim Journal: Am J Geriatr Psychiatry Date: 2013-01-11 Impact factor: 4.105
Authors: Jason Karlawish; Mark Cary; Stephen T Moelter; Andrew Siderowf; Elizabeth Sullo; Sharon Xie; Daniel Weintraub Journal: Neurology Date: 2013-07-26 Impact factor: 9.910
Authors: Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven Journal: Neurooncol Pract Date: 2020-07-16